Gene · 2516
Papers4,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors. | Neuroendocrinology | 2024 | 37699356 | PubTator, text mining | PubMed |
| A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features. | Int J Gynecol Pathol | 2024 | 37406360 | PubTator, text mining | PubMed |
| The genetic spectrum of a Chinese series of patients with 46, XY disorders of the sex development. | Andrology | 2024 | 37147882 | PubTator, text mining | PubMed |
| Transcription Factor Immunohistochemistry in the Classification of Pituitary Neuroendocrine Tumor/Adenoma: Proposal in a Limited-Resource Setting. | Arch Pathol Lab Med | 2024 | 37074863 | PubTator, text mining | PubMed |
| Microphase Separation Produces Interfacial Environment within Diblock Biomolecular Condensates. | bioRxiv | 2024 | 37034777 | PubTator, text mining | PubMed |
| PUBERTAL VIRILIZATION IN AN ADOLESCENT WITH 46, XY DISORDER OF SEXUAL DEVELOPMENT: A NOVEL MUTATION IN NR5A1 GENE. | Acta Endocrinol (Buchar) | 2023 | 38356974 | PubTator, text mining | PubMed |
| Immunohistochemical Analyses of Mammalian Target of Rapamycin (mTOR) Expression in Pituitary Neuroendocrine Tumors (PitNETs): mTOR as a Therapeutic Target for Functional PitNETs. | Acta Histochem Cytochem | 2023 | 38318106 | PubTator, text mining | PubMed |
| Transposable elements acquire time- and sex-specific transcriptional and epigenetic signatures along mouse fetal gonad development. | Front Cell Dev Biol | 2023 | 38283992 | PubTator, text mining | PubMed |
| From Genes to Therapy: Pituitary Adenomas in the Era of Precision Medicine. | Biomedicines | 2023 | 38275385 | PubTator, text mining | PubMed |
| Development of a tag-free plant-made interferon gamma production system with improved therapeutic efficacy against viruses. | Front Bioeng Biotechnol | 2023 | 38274005 | PubTator, text mining | PubMed |
| Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma. | Front Neurosci | 2023 | 38260014 | PubTator, text mining | PubMed |
| Luteinizing Hormone Surge-Induced Krüppel-like Factor 4 Inhibits Cyp17A1 Expression in Preovulatory Granulosa Cells. | Biomedicines | 2023 | 38255178 | PubTator, text mining | PubMed |
| Engineered Dynamic Hydrogel Niches for the Regulation of Redox Homeostasis in Osteoporosis and Degenerative Endocrine Diseases. | Gels | 2023 | 38247755 | PubTator, text mining | PubMed |
| NR5A1-related 46,XY partial gonadal dysgenesis: A case report and literature review. | Medicine (Baltimore) | 2023 | 38206718 | PubTator, text mining | PubMed |
| Prognostic Biomarkers in Pituitary Tumours: A Systematic Review. | touchREV Endocrinol | 2023 | 38187082 | PubTator, text mining | PubMed |
| A reappraisal of transcriptional regulation by NR5A1 and beta-catenin in adrenocortical carcinoma. | Front Endocrinol (Lausanne) | 2023 | 38155952 | PubTator, text mining | PubMed |
| Androgen excess: a hallmark of polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 38152131 | PubTator, text mining | PubMed |
| Stimuli-Responsive Protein Hydrogels: Their Design, Properties, and Biomedical Applications. | Polymers (Basel) | 2023 | 38139904 | PubTator, text mining | PubMed |
| Relevance of Molecular Pathology for the Diagnosis of Sex Cord-Stromal Tumors of the Ovary: A Narrative Review. | Cancers (Basel) | 2023 | 38136408 | PubTator, text mining | PubMed |
| Encapsulation of Leptadenia pyrotechnica (Khip) Extract in Carbomer Based Emulgel for Its Enhanced Antioxidant Effects and Its In Vitro Evaluation. | Gels | 2023 | 38131963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2516/papers?page=16